{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:46:36Z","timestamp":1782733596867,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/deed.de"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/deed.de"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00115-026-01985-0","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:21:54Z","timestamp":1780471314000},"page":"351-356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sp\u00e4tmanifestation des Morbus Tay-Sachs\u00a0\u2013 eine Erkrankung des Kleinhirns und der Motoneuronen mit psychiatrischen Folgen","Late-onset manifestation of Tay-Sachs disease\u2014A disease of the cerebellum and motor neurons with psychiatric sequelae"],"prefix":"10.1007","volume":"97","author":[{"given":"Karl Eugen","family":"Mengel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grecia","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latha","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Deckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Arash-Kaps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"25","key":"1985_CR1","doi-asserted-by":"publisher","first-page":"10195","DOI":"10.1523\/JNEUROSCI.0822-13.2013","volume":"33","author":"K Sandhoff","year":"2013","unstructured":"Sandhoff\u00a0K, Harzer\u00a0K (2013) Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis. J\u00a0Neurosci 33(25):10195\u201310208","journal-title":"J Neurosci"},{"issue":"2","key":"1985_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2174\/1566523218666180404162622","volume":"18","author":"MB Cachon-Gonzalez","year":"2018","unstructured":"Cachon-Gonzalez\u00a0MB, Zaccariotto\u00a0E, Cox\u00a0TM (2018) Genetics and Therapies for GM2 Gangliosidosis. Curr Gene Ther 18(2):68\u201389","journal-title":"Curr Gene Ther"},{"key":"1985_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.136195","volume":"764","author":"C Toro","year":"2021","unstructured":"Toro\u00a0C, Zainab\u00a0M, Tifft\u00a0CJ (2021) The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment. Neurosci Lett 764:136195","journal-title":"Neurosci Lett"},{"issue":"3","key":"1985_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1176\/jnp.16.3.367","volume":"16","author":"JD Schmahmann","year":"2004","unstructured":"Schmahmann\u00a0JD (2004) Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J\u00a0Neuropsychiatry Clin Neurosci 16(3):367\u2013378","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1985_CR5","doi-asserted-by":"crossref","unstructured":"Ries M, Mendoza G, Arash-Kaps L, Amraoui Y, Quack F, Hardt B, et\u00a0al. Quantitative longitudinal natural history of 8 gangliosidoses-conceptual framework and baseline data of the German 8\u2011in\u20111 disease registry. A\u00a0cross-sectional analysis. Genet Med. 2022.","DOI":"10.1101\/2022.04.13.22273562"},{"issue":"8","key":"1985_CR6","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s00415-019-09364-3","volume":"266","author":"H Jahnova","year":"2019","unstructured":"Jahnova\u00a0H, Poupetova\u00a0H, Jireckova\u00a0J, Vlaskova\u00a0H, Kostalova\u00a0E, Mazanec\u00a0R et\u00a0al (2019) Amyotrophy, cerebellar impairment and psychiatric disease are the main symptoms in a cohort of 14 Czech patients with the late-onset form of Tay-Sachs disease. J\u00a0Neurol 266(8):1953\u20131959","journal-title":"J Neurol"},{"issue":"4","key":"1985_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/ana.25689","volume":"87","author":"M Masingue","year":"2020","unstructured":"Masingue\u00a0M, Dufour\u00a0L, Lenglet\u00a0T, Saleille\u00a0L, Goizet\u00a0C, Ayrignac\u00a0X et\u00a0al (2020) Natural History of Adult Patients with GM2 Gangliosidosis. Ann Neurol 87(4):609\u2013617","journal-title":"Ann Neurol"},{"key":"1985_CR8","doi-asserted-by":"crossref","unstructured":"Lewis CJ, Shirvan L, Johnston JM, Groden C, Yang J, Ashton A, et\u00a0al. Similarities and Differences in the Late-Onset GM2 Gangliosidoses: Tay-Sachs and Sandhoff Diseases. medRxiv. 2025.","DOI":"10.1101\/2025.08.05.25333048"},{"issue":"5","key":"1985_CR9","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1007\/s10072-021-05757-3","volume":"43","author":"J Majovska","year":"2022","unstructured":"Majovska\u00a0J, Hennig\u00a0A, Nestrasil\u00a0I, Schneider\u00a0SA, Jahnova\u00a0H, Vaneckova\u00a0M et\u00a0al (2022) Pontocerebellar atrophy is the hallmark neuroradiological finding in late-onset Tay-Sachs disease. Neurol Sci 43(5):3273\u20133281","journal-title":"Neurol Sci"},{"issue":"6","key":"1985_CR10","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s00415-021-10492-y","volume":"268","author":"HT Holzer","year":"2021","unstructured":"Holzer\u00a0HT, Boschann\u00a0F, Hennermann\u00a0JB, Hahn\u00a0G, Hermann\u00a0A, von der Hagen\u00a0M et\u00a0al (2021) Cerebellar atrophy on top of motor neuron compromise as indicator of late-onset GM2 gangliosidosis. J\u00a0Neurol 268(6):2259\u20132262","journal-title":"J Neurol"},{"issue":"Pt 4","key":"1985_CR11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/brain\/121.4.561","volume":"121","author":"JD Schmahmann","year":"1998","unstructured":"Schmahmann\u00a0JD, Sherman\u00a0JC (1998) The cerebellar cognitive affective syndrome. Brain 121(Pt 4):561\u2013579","journal-title":"Brain"},{"issue":"5","key":"1985_CR12","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s12311-019-01060-2","volume":"18","author":"N Ahmadian","year":"2019","unstructured":"Ahmadian\u00a0N, van Baarsen\u00a0K, van Zandvoort\u00a0M, Robe\u00a0PA (2019) The Cerebellar Cognitive Affective Syndrome\u2011a Meta-analysis. Cerebellum 18(5):941\u2013950","journal-title":"Cerebellum"},{"key":"1985_CR13","doi-asserted-by":"crossref","unstructured":"Koutsouleris N, Buciuman MO, Vetter CS, Weyer CFC, Zhutovsky P, Perdomo ST et\u00a0al (2024) Distinct multimodal biological and functional profiles of symptom-based subgroups in recent-onset psychosis.","DOI":"10.21203\/rs.3.rs-3949072\/v1"},{"issue":"2","key":"1985_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1176\/appi.neuropsych.17110276","volume":"31","author":"KH Lee","year":"2019","unstructured":"Lee\u00a0KH, Oh\u00a0H, Suh\u00a0JS, Cho\u00a0KIK, Yoon\u00a0YB, Shin\u00a0WG et\u00a0al (2019) Functional and structural connectivity of the cerebellar nuclei with the striatum and cerebral cortex in first-episode psychosis. J\u00a0Neuropsychiatry Clin Neurosci 31(2):143\u2013151","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"1985_CR15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41588-019-0364-4","volume":"51","author":"LM Huckins","year":"2019","unstructured":"Huckins\u00a0LM, Dobbyn\u00a0A, Ruderfer\u00a0DM, Hoffman\u00a0G, Wang\u00a0W, Pardinas\u00a0AF et\u00a0al (2019) Gene expression imputation across multiple brain regions provides insights into schizophrenia risk. Nat Genet 51(4):659\u2013674","journal-title":"Nat Genet"},{"key":"1985_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.00177","volume":"7","author":"TM Cox","year":"2020","unstructured":"Cox\u00a0TM (2020) Lysosomal Diseases and Neuropsychiatry: Opportunities to Rebalance the Mind. Front Mol Biosci 7:177","journal-title":"Front Mol Biosci"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-026-01985-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-026-01985-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-026-01985-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:19:27Z","timestamp":1782731967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-026-01985-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1985"],"URL":"https:\/\/doi.org\/10.1007\/s00115-026-01985-0","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"K.E.\u00a0Mengel, G.\u00a0Mendoza, L.\u00a0Mani, J.\u00a0Deckert und L.\u00a0Arash-Kaps geben hinsichtlich LOTS und dieser Arbeit im Rahmen der 8\u00a0in\u00a01 Registerstudie keine Interessenkonflikte gegen\u00fcber Pharmafirmen an. Die Registerstudie wird aus Mitteln des Selbsthilfevereins Hand in Hand gegen Tay-Sachs, Sandhoff und GM1-Gangliosidose und der SphinCS finanziert. Die SphinCS erh\u00e4lt Mittel aus Forschungsvertr\u00e4gen und Beratervertr\u00e4gen von Sanofi, Amicus, Denali, JCR, Zevra, Intrabio, Genorph, Prevail, Spur Therapeutics, Cyclo Therapeutics und Alexion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}